However, for this strategy to work, antiviral stockpiles need to be sufficient to treat 50 percent of the populationtwice the number many countries are planning for.
The United States currently has enough antiviral drugs to treat one percent of the population, according to Neil Ferguson, lead author of the study. Ferguson is a professor of mathematical biology at Imperial College in London.
Other effective measures include keeping a vast stockpile of vaccine on hand, even if it's not perfectly matched to the outbreak strain, the researchers write.
Combined with an antiviral drug strategy, infection rates could be reduced by two-thirds, according to the results.
Border controls, however, are unlikely to delay the spread of influenza by more than a few weeks unless there is more than 99 percent compliance.
That level of compliance is difficult and costly to enforce in today's highly mobile society, Ferguson says.
"Frankly, different countries will be in different positions to implement one or more legs or arms of a combination strategy," Ferguson said.
For example, since Europe has greater stockpiles of antiviral drugs than the U.S., European countries can more aggressively pursue preventive treatment, he said.
Unless the U.S. can build its own stockpiles, the country should rely on a policy of social distancing: closing schools and telling infected people and their families to stay home, for example.
While social distancing will not stop people from getting ill, it may slow the disease spread, allowing researchers time to ramp up the vaccine manufacturing.
Prolonged and Severe
Ferguson and his colleagues' computer model assumed a strain of human influenza like the 1918 "Spanish flu" virus, which killed about five million people. (See "'Bird Flu' Similar to Deadly 1918 Flu, Gene Study Says.")
Ironically, a virus that causes a more prolonged and severe diseaseas some researchers suggest would be possible with a human version of the H5N1 bird flu strainmight be easier to control, the researchers said.
"If it's more severe, we will recognize cases more easily in the population," Ferguson said.
"That's what we saw with SARS [severe acute respiratory syndrome] in 2003: a uniformly severe disease, with people only becoming highly infectious when they were very ill."
Early recognition of cases would allow researchers time to treat and isolate individuals more readily than if the pandemic were less easily detectable and less severe, he added.
"I think the good news about influenza pandemic is it's not here and we don't know when it will be here," said Berg, of the National Institute of General Medical Sciences.
"There is an opportunity to prepare for this. It's not so imminent that efforts to prepare now are going to be in vain."
Free Email News Updates
Sign up for our Inside National Geographic newsletter. Every two weeks we'll send you our top stories and pictures (see sample).
SOURCES AND RELATED WEB SITES